Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis

In migraine patients with a poor response to a calcitonin gene-related peptide monoclonal antibody against the receptor, switching to a calcitonin gene-related peptide monoclonal antibodies against the ligand may be beneficial. This was a long-term real-world prospective analysis conducted in treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambru, Giorgio, Caponnetto, Valeria, Hill, Bethany, Ratti, Susanna, Sacco, Simona, Murphy, Madeleine, Briscoe, Jessica, Andreou, Anna P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480365/
https://www.ncbi.nlm.nih.gov/pubmed/37430146
http://dx.doi.org/10.1007/s13311-023-01394-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480365/
https://www.ncbi.nlm.nih.gov/pubmed/37430146
http://dx.doi.org/10.1007/s13311-023-01394-0

Ejemplares similares